Evidence map›Paper›PMID 34697059›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2022

Phenotype Discovery and Geographic Disparities of Late-Stage Breast Cancer Diagnosis across U.S. Counties: A Machine Learning Approach.

Weichuan Dong, Wyatt P Bensken, Uriel Kim, Johnie Rose, Nathan A Berger, Siran M Koroukian

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Gaps in artificial intelligence research for rural health in the United States: a scoping review.Journal of the American Medical Informatics Association : JAMIA · 2026
    Article
  5. Machine Learning Based County Level Phenotypes Related to Diabetes Prevalence.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Weichuan DongCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio. weichuan.dong@case.edu.ORCID 0000-0002-3981-658X
Wyatt P BenskenCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.ORCID 0000-0002-2597-9732
Uriel KimCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.ORCID 0000-0001-9910-0682
Johnie RoseCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Nathan A BergerCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.ORCID 0000-0001-7086-9885
Siran M KoroukianCase Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Multi-Level Interventions to Reduce Caries Disparities in Primary Care SettingsUH3DE025487 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI NELSON, SUCHITRA S. · 2017 to 2021
$5.6M
Optimizing Lung Transplant Benefit Using Agent-Based Simulation Modeling ApproachesR01HL153175 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI JARROD DALTON, JOHNIE ROSE · 2020 to 2026
$4.4M
Case CCC Youth Engaged in Science, 09/01/2022-08/31/2027R25CA221718 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Jason Mears · 2017 to 2026
$4.4M
Role of MYC-MIZ1 signaling and the inflammatory immune microenvironment in Triple-Negative Breast Cancer Racial DisparitiesP20CA233216 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI VARADAN, VINAY · 2018 to 2021
$3.6M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Cancer-focused Summer Undergraduate Research (CanSUR) ProgramR25CA225461 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK W. JACKSON · 2018 to 2026
$2.8M
Multi-Level Interventions to Reduce Caries Disparities in Primary Care SettingsUH2DE025487 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI NELSON, SUCHITRA S. · 2015 to 2016
$1.2M
Identifying Electronic Phenotypes associated with Patient Health Outcomes of Interhospital Transfer PatientsR15NR017792 · NINR · CASE WESTERN RESERVE UNIVERSITY · PI REIMER, ANDREW PAUL · 2018 to 2018
$477k
NCATS NIH HHS TL1 TR002549NCI NIH HHS P20 CA233216NCI NIH HHS P30 CA043703NCI NIH HHS P50 CA150964NCI NIH HHS R25 CA221718NCI NIH HHS R25 CA225461NCI NIH HHS U54 CA163060NHLBI NIH HHS R01 HL153175NIDCR NIH HHS UH2 DE025487NIDCR NIH HHS UH3 DE025487NIGMS NIH HHS T32 GM007250NIMHD NIH HHS F31 MD015681NINR NIH HHS R15 NR017792
6 · The paper itself

Abstract

backgroundDisparities in the stage at diagnosis for breast cancer have been independently associated with various contextual characteristics. Understanding which combinations of these characteristics indicate highest risk, and where they are located, is critical to targeting interventions and improving outcomes for patients with breast cancer.

methodsThe study included women diagnosed with invasive breast cancer between 2009 and 2018 from 680 U.S. counties participating in the Surveillance, Epidemiology, and End Results program. We used a machine learning approach called Classification and Regression Tree (CART) to identify county "phenotypes," combinations of characteristics that predict the percentage of patients with breast cancer presenting with late-stage disease. We then mapped the phenotypes and compared their geographic distributions. These findings were further validated using an alternate machine learning approach called random forest.

resultsWe discovered seven phenotypes of late-stage breast cancer. Common to most phenotypes associated with high risk of late-stage diagnosis were high uninsured rate, low mammography use, high area deprivation, rurality, and high poverty. Geographically, these phenotypes were most prevalent in southern and western states, while phenotypes associated with lower percentages of late-stage diagnosis were most prevalent in the northeastern states and select metropolitan areas.

conclusionsThe use of machine learning methods of CART and random forest together with geographic methods offers a promising avenue for future disparities research. IMPACT: Local interventions to reduce late-stage breast cancer diagnosis, such as community education and outreach programs, can use machine learning and geographic modeling approaches to tailor strategies for early detection and resource allocation.

Indexed as

Machine LearningResidence CharacteristicsAdultAgedBreast NeoplasmsFemaleHumansMammographyMedically UninsuredMiddle AgedNeoplasm InvasivenessPhenotypePoverty AreasRural PopulationSEER ProgramUnited States

Identifiers

PMID34697059
PMCPMC8755627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.